Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:15 AM
Ignite Modification Date:
2025-12-25 @ 12:15 AM
NCT ID:
NCT02729558
Eligibility Criteria:
Inclusion Criteria:
* Age of 18 years or older.
* Radiologically confirmed complete resection of a single brain metastasis on a contrast-enhanced MRI within 72 h after resection.
* Primary solid tumor, excluding hematologic malignancy, germ cell tumor, small cell lung cancer.
* Stable extracranial tumor (primary tumor and/or systemic metastases) during the last three months with or without treatment or progressive extracranial tumor and/or systemic metastases for which effective treatment is available.
* World Health Organization (WHO) performance score 0-2.
* Ability to provide written informed consent.
Exclusion Criteria:
* Prior treatment for brain metastases (i.e. surgery, stereotactic radiotherapy or WBRT).
* Distant brain metastases or radiological findings on MRI suspected for leptomeningeal tumor spread on the postoperative MRI.
* Concurrent use of systemic therapy during local stereotactic radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02729558
Study Brief:
Protocol Section:
NCT02729558